New Key Statistics Module, Z-Score and F-Score
SHSE:600351 Key Ratios
Market Cap ¥ M | 4,629.60 |
Enterprise Value ¥ M | 4,217.27 |
P/E(ttm) | 22.88 |
PE Ratio without NRI | 17.66 |
Forward PE Ratio | -- |
Price/Book | 1.62 |
Price/Sales | 1.58 |
Price/Free Cash Flow | 10.21 |
Price/Owner Earnings | 39.21 |
Payout Ratio % | 0.14 |
Revenue (TTM) ¥ M | 2,944.00 |
EPS (TTM) ¥ | 0.28 |
Beneish M-Score | -2.86 |
10-y EBITDA Growth Rate % | 0.30 |
5-y EBITDA Growth Rate % | -6.50 |
y-y EBITDA Growth Rate % | 43.40 |
EV-to-EBIT | 16.30 |
EV-to-EBITDA | 16.30 |
PEG | -- |
Shares Outstanding M | 720.00 |
Net Margin (%) | 7.19 |
Operating Margin % | 11.29 |
Pre-tax Margin (%) | 8.25 |
Quick Ratio | 1.68 |
Current Ratio | 2.18 |
ROA % (ttm) | 5.18 |
ROE % (ttm) | 7.01 |
ROIC % (ttm) | 9.67 |
Dividend Yield % | 0.78 |
Altman Z-Score | 4.84 |
SHSE:600351 Number of Guru Trades
SHSE:600351 Volume of Guru Trades
Gurus Latest Trades with SHSE:600351
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:600351 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Yabao Pharmaceutical Group Co Ltd Insider Transactions
No Available Data